Story perspectives
Fentanyl Vaccine Trials Begin to Combat Overdose Crisis
12/4/2025
50 5
1 of 1
Story summary
- ARMR Sciences, a New York biotech company, is developing a fentanyl vaccine to prevent overdose deaths.
- Fentanyl accounted for nearly 70% of overdose fatalities in 2023.
- Gage, ARMR Sciences' CEO, emphasizes a proactive overdose-prevention approach.
- The vaccine could block fentanyl from entering the brain and will begin trials with 40 healthy adults in the Netherlands early next year.
